Phase 4

Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations

May 29, 2020

https://clinicaltrials.gov/ct2/show/NCT03624101?recrs=abdf

https://clinicaltrials.gov/ct2/show/NCT03624101?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=05%2F15%2F2020&lupd_d=14

Condition : Cystic Fibrosis

Intervention : Drug: Tezacaftor/Ivacaftor

Sponsor : University of Alabama at Birmingham

Recruiting

Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations

NCT03624101

Thu, 09 Aug 2018 12:00:00 EDT

Last Update Posted: 05/29/20 06:52AM

Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations

May 17, 2019

https://clinicaltrials.gov/ct2/show/NCT03624101?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=05%2F03%2F2019&lupd_d=14

Condition : Cystic Fibrosis

Intervention : Drug: Tezacaftor/Ivacaftor

Sponsor : University of Alabama at Birmingham

Recruiting

Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations

NCT03624101

Thu, 09 Aug 2018 12:00:00 EDT

Last Update Posted: 05/17/19 07:16AM

Back to top